Stage-specific alterations in serum levels of G-CSF in chronic myeloid leukaemia [10]

Leukemia

Volumn 17, Issue 7, 2003, Pages 1430-1432

  Jorgensen H G ^a   Allan, E K ^a,b   Jiang, X ^c   Liakopoulou, E ^d   Richmond, L ^d   Eaves, C J ^c   Eaves, A C ^c   Holyoake, T L ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

^d GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYUREA; IMATINIB; INTERLEUKIN 3;

BLOOD ANALYSIS; BLOOD SAMPLING; BONE MARROW TRANSPLANTATION; CANCER REGRESSION; CANCER STAGING; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; LETTER; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SECRETION; TREATMENT OUTCOME;

EID: 0037765515     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402967     Document Type: Letter

References (8)

1. Sattler M, Salgia R. Activation of hematopoietic growth factor signal transduction pathways by the human oncogene BCR/ABL. Cytokine Growth Factor Rev 1997; 8: 63-79.
2. Jiang X, Lopez A, Holyoake T, Eaves A, Eaves C. Autocrine production and action of IL-3 and granulocyte colony-stimulating factor in chronic myeloid leukaemia. Proc Nat Acad Sci USA 1999; 96: 12804-12809.
3. Jiang X, Fujisaki T, Nicolini F, Berger M, Holyoake T, Eisterer W et al. Autonomous multi-lineage differentiation in vitro of primitive CD34+ cells from patients with chronic myeloid leukemia. Leukemia 2000; 14: 1112-1121.
4. Hariharan IK, Adams JM, Cory S. BCR-ABL oncogene renders myeloid cell line factor independent: Potential autocrine mechanism in chronic myeloid leukemia. Oncogene Res. 1988; 3: 387-399.
5. Sirard C, Laneuville P, Dick J. Expression of bcr-abl abrogates factor-dependent growth of human hematopoietic M07E cells by an autocrine mechanism. Blood 1994; 83: 1575-1585.
6. Li S, Ilaria RL, Million RP, Daley GQ, Van Etten RA. The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. J Exp Med 1999; 189: 1399-1412.
7. Zhang X, Ren R. BCR-ABL efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: a novel model for chronic myelogenous leukemia. Blood 1998; 92: 3829-3840.
8. BCR-ABL activity in transduced primary human hematopoietic cells controls lineage programming. Blood 2002; 99: 3197-3204.